Price to Book Value (P/BV)
since 2005
Calculation
Cytokinetics Inc., P/BV, long-term trends, calculation
| P/BV | = | Share price1, 2, 3 | ÷ | Book value per share1 (BVPS) | BVPS1 | = | Stockholders’ equity (deficit)1 (in thousands) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 1, 2023 | — | = | 43.11 | ÷ | -1.13 | -1.13 | = | -107,900 | ÷ | 95,161,391 | |
| Feb 25, 2022 | 12.19 | = | 35.02 | ÷ | 2.87 | 2.87 | = | 243,863 | ÷ | 84,856,037 | |
| Feb 26, 2021 | 11.75 | = | 18.73 | ÷ | 1.59 | 1.59 | = | 113,383 | ÷ | 71,110,576 | |
| Mar 4, 2020 | — | = | 14.86 | ÷ | -0.18 | -0.18 | = | -10,937 | ÷ | 59,450,437 | |
| Mar 7, 2019 | 12.72 | = | 6.01 | ÷ | 0.47 | 0.47 | = | 25,934 | ÷ | 54,888,369 | |
| Mar 5, 2018 | 4.11 | = | 8.35 | ÷ | 2.03 | 2.03 | = | 109,842 | ÷ | 54,008,113 | |
| Mar 6, 2017 | 5.24 | = | 11.85 | ÷ | 2.26 | 2.26 | = | 94,361 | ÷ | 41,729,549 | |
| Mar 3, 2016 | 3.75 | = | 6.50 | ÷ | 1.73 | 1.73 | = | 68,590 | ÷ | 39,592,808 | |
| Mar 6, 2015 | 3.28 | = | 7.80 | ÷ | 2.38 | 2.38 | = | 92,064 | ÷ | 38,674,892 | |
| Mar 7, 2014 | 6.77 | = | 10.21 | ÷ | 1.51 | 1.51 | = | 54,442 | ÷ | 36,078,367 | |
| Mar 15, 2013 | 2.16 | = | 6.30 | ÷ | 2.91 | 2.91 | = | 70,085 | ÷ | 24,077,245 | |
| Mar 13, 2012 | 1.85 | = | 7.02 | ÷ | 3.78 | 3.78 | = | 48,178 | ÷ | 12,729,467 | |
| Mar 11, 2011 | 1.44 | = | 9.12 | ÷ | 6.32 | 6.32 | = | 70,516 | ÷ | 11,151,683 | |
| Mar 11, 2010 | 2.07 | = | 20.16 | ÷ | 9.74 | 9.74 | = | 101,428 | ÷ | 10,410,819 | |
| Mar 12, 2009 | 2.14 | = | 12.00 | ÷ | 5.61 | 5.61 | = | 49,766 | ÷ | 8,869,882 | |
| Mar 12, 2008 | 1.52 | = | 18.54 | ÷ | 12.16 | 12.16 | = | 99,916 | ÷ | 8,216,883 | |
| Mar 12, 2007 | 3.31 | = | 45.06 | ÷ | 13.63 | 13.63 | = | 106,313 | ÷ | 7,802,005 | |
| Mar 10, 2006 | 3.46 | = | 42.90 | ÷ | 12.41 | 12.41 | = | 73,561 | ÷ | 5,927,659 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Cytokinetics Inc. Annual Report.
Comparison to Competitors
Cytokinetics Inc., P/BV, long-term trends, comparison to competitors
| Cytokinetics Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Moderna Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 1, 2023 | — | 15.52 | 35.01 | 4.88 | 3.64 | 29.36 | 4.90 | 5.37 | 6.07 | 2.81 | 2.48 | 3.77 | 4.83 |
| Feb 25, 2022 | 12.19 | 16.53 | 18.51 | 4.07 | 4.16 | 25.28 | 3.65 | 5.90 | 5.05 | 4.31 | 3.35 | 3.60 | 5.18 |
| Feb 26, 2021 | 11.75 | 14.18 | 14.53 | 3.55 | 3.93 | 35.07 | 4.33 | 6.72 | 7.46 | 24.16 | 2.98 | 4.81 | 5.15 |
| Mar 4, 2020 | — | — | 13.84 | 2.80 | 3.72 | 51.67 | 3.93 | 6.61 | 7.83 | 8.21 | 3.00 | 3.79 | 4.16 |
| Mar 7, 2019 | 12.72 | — | 9.41 | 5.89 | 2.80 | 12.87 | 3.89 | 6.08 | 7.79 | 4.29 | 3.80 | 5.07 | 3.75 |
| Mar 5, 2018 | 4.11 | 36.95 | 5.02 | 8.88 | 2.58 | 7.33 | 5.15 | 5.79 | 4.30 | — | 2.94 | 5.66 | 3.30 |
| Mar 6, 2017 | 5.24 | 21.24 | 4.14 | 5.66 | 2.56 | 6.33 | 4.88 | 4.72 | 4.51 | — | 3.40 | 8.58 | 2.86 |
| Mar 3, 2016 | 3.75 | 22.17 | 3.94 | 7.04 | 2.53 | 5.51 | 6.59 | 4.07 | 3.15 | — | 2.84 | 10.53 | 2.42 |
| Mar 6, 2015 | 3.28 | 56.09 | 4.59 | 6.72 | 2.63 | 5.14 | 10.08 | 4.01 | 3.42 | — | 2.95 | 16.22 | 2.51 |
| Mar 7, 2014 | 6.77 | 18.05 | 4.30 | 5.92 | 2.38 | 3.69 | 11.36 | 3.50 | 3.35 | — | 2.69 | 16.74 | 2.90 |
| Mar 15, 2013 | 2.16 | 18.06 | 3.57 | 4.40 | 2.23 | 4.15 | 7.01 | 3.29 | 2.44 | — | 2.42 | 12.91 | 1.72 |
| Mar 13, 2012 | 1.85 | — | 2.83 | 3.50 | 2.17 | 3.35 | 5.08 | 3.13 | 2.14 | — | 1.95 | 19.19 | 1.38 |
| Mar 11, 2011 | 1.44 | — | 2.04 | 2.76 | 2.39 | 3.21 | 5.29 | 2.88 | 1.85 | — | 1.75 | 6.42 | 1.41 |
| Mar 11, 2010 | 2.07 | — | 2.46 | 2.88 | 2.07 | 4.17 | 6.74 | 3.45 | 1.97 | — | 1.57 | 5.49 | 1.29 |
| Mar 12, 2009 | 2.14 | — | 2.48 | 3.29 | 1.69 | 5.01 | 9.83 | 3.56 | 2.72 | — | 1.44 | 2.94 | 1.02 |
| Mar 12, 2008 | 1.52 | — | 2.77 | 4.22 | 2.62 | 4.16 | 11.76 | 4.17 | 5.38 | — | 2.32 | 3.24 | 1.62 |
| Mar 12, 2007 | 3.31 | — | 3.96 | 5.50 | 3.32 | 5.43 | 18.07 | 4.78 | 5.45 | — | 2.49 | 5.77 | 1.38 |
| Mar 10, 2006 | 3.46 | — | 4.26 | 4.00 | 3.78 | 5.85 | 9.18 | 4.66 | 4.30 | — | 2.94 | 8.16 | 2.03 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Cytokinetics Inc., P/BV, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
| Cytokinetics Inc. | Pharmaceuticals, Biotechnology & Life Sciences | |
|---|---|---|
| Mar 1, 2023 | — | 5.54 |
| Feb 25, 2022 | 12.19 | 5.66 |
| Feb 26, 2021 | 11.75 | 6.13 |
| Mar 4, 2020 | — | 5.74 |
| Mar 7, 2019 | 12.72 | 5.93 |
| Mar 5, 2018 | 4.11 | 5.04 |
| Mar 6, 2017 | 5.24 | 4.52 |
| Mar 3, 2016 | 3.75 | 4.10 |
| Mar 6, 2015 | 3.28 | 4.40 |
| Mar 7, 2014 | 6.77 | 3.93 |
| Mar 15, 2013 | 2.16 | 3.19 |
| Mar 13, 2012 | 1.85 | 2.53 |
| Mar 11, 2011 | 1.44 | 2.23 |
| Mar 11, 2010 | 2.07 | 2.35 |
| Mar 12, 2009 | 2.14 | 2.58 |
| Mar 12, 2008 | 1.52 | 3.41 |
| Mar 12, 2007 | 3.31 | 3.81 |
| Mar 10, 2006 | 3.46 | 3.98 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Cytokinetics Inc., P/BV, long-term trends, comparison to industry (health care)
| Cytokinetics Inc. | Health Care | |
|---|---|---|
| Mar 1, 2023 | — | 71,951.01 |
| Feb 25, 2022 | 12.19 | 4.78 |
| Feb 26, 2021 | 11.75 | 4.66 |
| Mar 4, 2020 | — | 4.41 |
| Mar 7, 2019 | 12.72 | 4.42 |
| Mar 5, 2018 | 4.11 | 4.25 |
| Mar 6, 2017 | 5.24 | 3.83 |
| Mar 3, 2016 | 3.75 | 3.47 |
| Mar 6, 2015 | 3.28 | 3.90 |
| Mar 7, 2014 | 6.77 | 3.30 |
| Mar 15, 2013 | 2.16 | 2.70 |
| Mar 13, 2012 | 1.85 | 2.38 |
| Mar 11, 2011 | 1.44 | 2.11 |
| Mar 11, 2010 | 2.07 | 2.23 |
| Mar 12, 2009 | 2.14 | 2.42 |
| Mar 12, 2008 | 1.52 | 3.26 |
| Mar 12, 2007 | 3.31 | 3.75 |
| Mar 10, 2006 | 3.46 | 3.89 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).